Investing.com -- L’Oreal, the global cosmetics giant, has purchased stakes in medical clinics in China and North America, according to the company’s CEO, Nicolas Hieronimus. The move is part of L’Oreal’s strategy to gain a deeper understanding of the medical aesthetics market.
The company had previously disclosed its acquisition of a 10% stake in Galderma, a Swiss skin care firm, back in August. This decision aligns with the company’s broader intention to expand its footprint in the skincare industry.
Additionally, Hieronimus revealed that L’Oreal is planning to penetrate the nutricosmetics market. He hinted at the upcoming launch of a new product, promising that more will follow. Nutricosmetics are dietary supplements or foods that promote skin health, a growing segment in the global beauty industry.
The CEO did not provide further details about the new product or the timeline for its launch. However, the company’s strategic moves indicate a focus on diversifying its portfolio and exploring new market opportunities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.